Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) — Financial Flexibility Index
Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) has a Financial Flexibility Index of 0.85x as of September 2025. Free cash flow of CN¥609.18 Million (operating CF CN¥504.02 Million minus capex CN¥105.16 Million) represents 1% of total liabilities (CN¥719.98 Million). Check Chengdu Kanghong Pharmaceuticals Group C investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chengdu Kanghong Pharmaceuticals Group Co Ltd Financial Flexibility Index (2009–2025)
Historical Financial Flexibility Index trend for Chengdu Kanghong Pharmaceuticals Group Co Ltd across 17 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Chengdu Kanghong Pharmaceuticals Group C.
Annual Financial Flexibility Index for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
Year-by-year free cash flow to debt coverage for Chengdu Kanghong Pharmaceuticals Group Co Ltd. Explore Chengdu Kanghong Pharmaceuticals Group C (002773) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.74x | CN¥1.77 Billion | CN¥1.50 Billion | CN¥645.22 Million | ▲ +21.1% |
| 2024 | 2.26x | CN¥1.57 Billion | CN¥1.41 Billion | CN¥695.07 Million | ▲ +19.5% |
| 2023 | 1.89x | CN¥1.36 Billion | CN¥1.22 Billion | CN¥717.76 Million | ▲ +20.2% |
| 2022 | 1.57x | CN¥1.28 Billion | CN¥925.15 Million | CN¥813.85 Million | ▲ +25.9% |
| 2021 | 1.25x | CN¥1.06 Billion | CN¥494.11 Million | CN¥851.08 Million | ▲ +75.0% |
| 2020 | 0.71x | CN¥890.38 Million | CN¥273.32 Million | CN¥1.25 Billion | ▼ -51.5% |
| 2019 | 1.47x | CN¥1.78 Billion | CN¥812.15 Million | CN¥1.21 Billion | ▲ +102.0% |
| 2018 | 0.73x | CN¥809.33 Million | CN¥350.88 Million | CN¥1.11 Billion | ▼ -29.6% |
| 2017 | 1.04x | CN¥1.08 Billion | CN¥766.86 Million | CN¥1.04 Billion | ▼ -13.1% |
| 2016 | 1.19x | CN¥1.02 Billion | CN¥846.35 Million | CN¥853.27 Million | ▼ -25.0% |
| 2015 | 1.59x | CN¥597.80 Million | CN¥481.97 Million | CN¥376.19 Million | ▲ +37.0% |
| 2014 | 1.16x | CN¥381.65 Million | CN¥291.38 Million | CN¥329.11 Million | ▼ -13.6% |
| 2013 | 1.34x | CN¥410.47 Million | CN¥333.31 Million | CN¥305.69 Million | ▲ +22.5% |
| 2012 | 1.10x | CN¥411.35 Million | CN¥281.84 Million | CN¥375.39 Million | ▲ +20.8% |
| 2011 | 0.91x | CN¥326.11 Million | CN¥168.86 Million | CN¥359.58 Million | ▲ +23.7% |
| 2010 | 0.73x | CN¥268.56 Million | CN¥136.79 Million | CN¥366.21 Million | ▼ -22.0% |
| 2009 | 0.94x | CN¥266.69 Million | CN¥108.42 Million | CN¥283.73 Million | — |